CLC Number:
- R473.73
| [1] Zhang RX, Wu XJ, Wan DS,et al.Celecoxib can preventcapecitabine-related handfoot syndrome in stage Il and IIlcolorectal cancer patients: result of a single-center, prospective randomized phase III trial[J]. Ann Oncol, 2012, 23(5):1348-1353.DOI: 10.1093/annonc/mdr400. [2] Heo YS,Chang HM, Kim TW,et al.Hand-foot syndrome inpatients treated with capecitabine-containingcombination-chemotherapy[J]. J Clin Pharmacol, 2004, 44(10):1166-1172.DOI: 10.1177/0091270004268321. [3] Benson AB, Venook AP, Al-Hawary MM, et a1. Colon cancer, version 2.2021,NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021,19(3):329-359. DOI:10.6004/jnccn.2021.0012. [4] 董元鸽,陆箴琦,杨瑒.卡培他滨致手足综合征的护理研究进展[J].护理研究(下旬版),2016(1):275-278. [5] 黄玉,王绍霞.恶性肿瘤化疗所致手足综合征国内外研究进展[J].中医临床研究,2018,10(3):86-89. [6] Sail MW.Capecitabine and hand—foot syndrome[J].J Expert Opin Drug Saf,2011, 10(2):159-169.DOI:10.1517/14740338.2011.546342. [7] Hofheinz RD, Cencer D,Schulz H,et al.Mapisal versus urea cream as prophylaxis for capecitabine-associated hand-foot syndrome: a randomized phase Ⅲ trial of the AIO quality of life working group[J]. J Clin Oncol,2015,33(22):2444-2449.DOI: 10.1200/JCO.2014.60.4587. [8] 梁琳春,褚斌斌.尿素乳膏联合VitB6防治手足综合征的临床观察[J].现代实用医学,2015,27(3):397-416. [9] Jacobi U,Waibler E,Schulze P,et a1.Release of doxorubicin in sweat:first step to induce the Palmar-plantar erythrodysesthesia syndrome?[J].Ann Oncol, 2005, 16(7):1210-1211.DOI: 10.1093/annonc/mdi204. [10] Yoshifuku A, Higashi Y, Matsushita S, et al.Transdermal nicotine patches for eosinophilic pustular folliculitis[J]. J Dermatol, 2013, 40(9):711-714.DOI:10.1111/1346-8138.12211. [11] 周胜涟,陈州华,徐婪,等. 芪归通络汤防治化疗后手足综合征的临床研究[J].湖南中医杂志,2016,32(9):11-14.DOI:10.16808/j.cnki.issn1003-7705.2016.09.004. [12] 陈红英,沙建飞,顾永伟.参地二仙汤治疗卡培他滨所致的手足综合征37例[J].陕西中医,2015(6):714-715. [13] 黄映飞,郭智涛.黄芪桂枝五物合补阳还五汤外用熏洗防治乳腺癌希罗达手足综合征52例临床观察[J].中外医学研究,2014,12(34):43-44.DOI:10.14033/j.cnki.cfmr.2014.34.024. [14] 李小军,冯春兰,罗海亮,等.八珍汤辅助化疗治疗中晚期食管癌45例临床观察[J].中医杂志,2016,57(5):416-419.DOI:10.13288/j.11-2166/r.2016.05.014. [15] 袁春樱,黄琼,韩伍龙.黄芪桂枝五物汤合当归四逆汤外洗防治卡培他滨所致手足综合征的临床观察[J].黑龙江中医药,2014(5):31-32. [16] 程小伟,吴锐荣,张振勇,等.中药熏洗治疗结直肠癌患者化疗后手足综合征的疗效观察[J].实用临床医药杂志,2020,24(21):32-35. [17] 张方圆,吕苏梅,杨玄,等.中国癌症症状管理实践指南——皮肤反应[J].护士进修杂志,2019,34(22):2017-2024.DOI:10.16821/j.cnki.hsjx.2019.22.001. [18] 崔秀秀,黄敬文,安丽凤,等.中药三七及其活性成分促进皮肤创面愈合的研究进展[J].现代中西医结合杂志,2023,32(21):3038-3043. [19] 廖佳伟,金晨,陈志,等.鸡血藤化学成分、药理作用研究进展及其质量标志物(Q-Marker)预测[J].中草药,2023,54(20):6866-6877. [20] 王彤,王崇静,王珩,等.龙血竭的临床应用研究概况[J].中国医药创新,2015,12(16):154-156. [21] National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE)[EB/OL].(2018-03-11)[2019-09-04].https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. [22] Abushullaih S, Saad ED, Munsell M, et al.Incidence and severity of hand-foot syndrome in eolorectal cancer patients treated with cape cita bine: a single-institution experience[J]. Cancer Invest, 2002, 20(1):3-10.DOI: 10.1081/cnv-120000360. [23] 王君,徐力.社区管理模式对中晚期肺癌癌痛患者生活质量的研究[J]. 中医临床研究,2018,10(5):24-26. [24] 马国华. 三七散、三七粉联合用药预防人工膝关节置换术后DVT的临床观察[J].中国现代药物应用,2017,11(17):139-140.DOI:10.14164/j.cnki.cn11-5581/r.2017.17.078. [25] 康梦娇,张伟,林潼,等.重构本草——鸡血藤[J].吉林中医药,2023,43(1):95-98.DOI:10.13463/j.cnki.jlzyy.2023.01.023. [26] 盖龙娴,武霞.湿润烧伤膏联合龙血竭防治乳腺癌改良根治术后放射性皮肤损伤疗效观察[J]. 中国烧伤创疡杂志,2020,32(3):202-206. [27] 赵德华,王继生,楚明明,等.抗肿瘤药物引起手足综合征的机制及防治措施[J]. 中国现代应用药学,2019(11):1437-1442.DOI:10.13748/j.cnki.issn1007-7693.2019.11.026. |
| [1] | QIAN Da-di, ZHOU Hong-zhen, WANG Hong-xiao, DENG Shui-juan, LONG Hao. Experience of undergoing gamma knife radiosurgery in patients with intracranial tumor: a qualitative research [J]. Journal of Nursing, 2024, 31(11): 6-11. |
| [2] | . [J]. Journal of Nursing, 2024, 31(10): 33-36. |
| [3] | . [J]. Journal of Nursing, 2024, 31(8): 49-54. |
| [4] | . [J]. Journal of Nursing, 2024, 31(8): 60-62. |
| [5] | CHEN Rui, WANG Mei, TANG Xiao-xia, ZHU Ao-xue, MAO Hui-na. Construction of nursing need protocol for cancer patients receiving immune checkpoint inhibitor therapy based on ERG theory [J]. Journal of Nursing, 2024, 31(7): 1-5. |
| [6] | ZHOU Yi-feng, YANG Ji-ping, HU Zheng-zhong, YUAN Hao. Evidence summary for target-oriented blood glucose monitoring in patients undergoing hepatocellular carcinoma resection [J]. Journal of Nursing, 2024, 31(7): 46-50. |
| [7] | . [J]. Journal of Nursing, 2024, 31(6): 73-78. |
| [8] | DUAN Nai-juan, SUN Li, LI Feng-xia, ZHANG Hui. Construction of participatory art therapy intervention scheme for cervical cancer patients and their spouses based on Dyadic Coping Theory [J]. Journal of Nursing, 2024, 31(5): 7-11. |
| [9] | . [J]. Journal of Nursing, 2024, 31(4): 12-16. |
| [10] | . [J]. Journal of Nursing, 2024, 31(4): 60-64. |
| [11] | SONG Cai-ni, ZHENG Yao, SONG Ying, Liu Li-hua. Translation of Information Concealment Scale for cancer caregiver and its reliability and validity in caregiver of lung cancer patients [J]. Journal of Nursing, 2024, 31(3): 17-20. |
| [12] | HAN Shuang-rong, LI Qiu-fang, LUO Hao-yue, YANG Jia-yin, LIU La-mei, WANG Xiao-kai. Potential profile analysis of self-pity in lung cancer patients undergoing chemotherapy and its relationship with despair [J]. Journal of Nursing, 2024, 31(2): 65-69. |
| [13] | GAO Ruo-nan, WANG Cui-ling, LI Ting-yu, TIAN Mei-yu, ZHANG Nan, ZHENG Rui. Construction of a dietary management program for postoperative oesophageal cancer patients based on Pender's health promotion model [J]. Journal of Nursing, 2024, 31(1): 12-16. |
| [14] | . [J]. Journal of Nursing, 2023, 30(24): 24-26. |
| [15] | TAN Jian-feng, WANG Yong-cun, ZHENG Xiu-ying, WANG Zheng-ye, LIU yan-hua. Psychological experience and benefit finding in young breast cancer patients during convalescence: a qualitative study [J]. Journal of Nursing, 2023, 30(23): 73-78. |
|